Capella BioScience's Series A Round

Capella BioScience raised a round of funding on March 08, 2016.

Capella BioScience uses technologies to develop novel medicines based on monoclonal antibodies (mAbs) to the next generation of important therapeutic targets in oncology and autoimmune disease.…

Articles about Capella BioScience's Series A Round: